Skip to content

Welcome to the new Aloha Fungi shop!Have a question or an idea? Message us on WhatsApp: MattKubaFranek

Frequently asked questions about Reishi

Ganoderma lucidum, Ling zhi, the shining lacquer bracket. We answer the most common questions about origin, naming and safety of the Reishi mushroom.

Mateusz Rosa

TCM therapist · Doctor of Acupuncture (WFAS) · author of a book on functional mushrooms

4 min read

Frequently asked questions about Reishi
Contents

Reishi comes up in conversations about functional mushrooms more often than almost any other species, and with it come the same handful of questions. We've gathered the answers in one place, short and checkable, without marketing.

What is Ganoderma lucidum?

Ganoderma lucidum is a mushroom that grows on dead tree stumps, and sometimes on living trees, mainly deciduous ones. The Latin name breaks into three parts: gan (to shine), derma (skin), and lucidum (shining), referring to the fruiting body's characteristic lacquered surface.

Are Ganoderma lucidum, Reishi, Ling zhi and the shining lacquer bracket the same mushroom?

Yes, it's one species under four names from different languages. Ganoderma lucidum is the Latin (scientific) name, Reishi is the Japanese name, Ling zhi (Lingzhi) is the Chinese name, and the shining lacquer bracket is the English common name. In popular texts these names are used interchangeably.

Does Reishi have anything to do with kombucha or "tea mushrooms"?

No. Reishi is the hard, woody fruiting body of a bracket fungus, biologically and in cultivation terms entirely unrelated to kombucha or other home-fermented cultures. Reishi cannot be grown in a jar on a kitchen counter, it requires specialized cultivation on wood or a wood-based substrate over many months.

Does Ganoderma lucidum grow in Poland?

Yes, though very rarely. Its Polish name is lakownica lśniąca, and the species is under protected status in Poland due to low numbers in the wild. The raw material used in supplements comes from controlled cultivation, not from wild-harvested fruiting bodies.

What compounds are studied in Reishi?

Scientific literature studies Reishi mainly for three groups of compounds: triterpenes (including ganoderic acids), β-glucans and peptidoglycans. We describe their mechanisms in detail, including their role in HPA axis regulation and immunomodulation, in How does Reishi work and What are β-glucans. Traditionally in Chinese medicine, Reishi was classified as a shang yao herb, the highest class of regulators. This is a cultural and traditional description, not a list of confirmed medicinal effects.

Is Reishi safe for typical use?

In the literature, Reishi is described as well tolerated by most people, with rare and usually mild side effects, most commonly gastrointestinal discomfort in the first days of use. It is a biologically active extract, not a neutral tea, so the decision to supplement is worth discussing with a doctor or pharmacist, especially if you have a chronic condition.

Does Reishi cause hallucinations or have psychoactive effects?

No. Reishi does not contain psilocybin or other psychoactive substances, and the literature does not describe hallucinogenic effects related to its consumption. Visual effects associated with certain mushrooms come from entirely different chemical compounds, which Reishi does not contain.

Can Reishi use become habit-forming?

The literature does not describe any addictive potential for Reishi. The mushroom does not act on dopaminergic or opioid receptors in a way linked to the addiction mechanisms known from psychoactive substances.

When should you consult a doctor about Reishi?

Always, if you take medication regularly, especially blood thinners (anticoagulants), immunosuppressants or hypoglycemic medication, if you're pregnant or breastfeeding, have a chronic condition, or have surgery planned in the coming weeks. Some studies show weak anticoagulant and glucose-affecting activity for Reishi, so these situations require individual assessment by a doctor or pharmacist, not a self-made decision. We cover these medication groups in detail in our post on Reishi and medication interactions.

Does Reishi powder work the same as an extract?

Not quite, the difference lies in the concentration of active compounds. Raw fruiting-body powder typically contains 7-15% β-glucans, while a standardized 10:1 fruiting-body extract contains above 30%. This is a real chemical difference, not a marketing distinction, which we cover in more detail in our article on β-glucans.

How long does it take to use Reishi before noticing an effect?

There's no single answer, since every body responds differently, and supplementation is just one of many factors affecting how you feel. Our practical suggestion is to think in terms of at least several weeks of regular use, paying attention to your own body rather than expecting an immediate result. If you're curious how Reishi fits into a daily rhythm, read about the evening ritual with Reishi.


This content is for educational purposes only and does not constitute medical advice. A food supplement does not replace a varied diet or a healthy lifestyle. If in doubt, consult your doctor or pharmacist.

Reishi in scientific research

What was studied, on how many people and with what level of evidence. This overview describes studies, not the effects of a product.

8

human studies

3

placebo-controlled RCTs

2005–2025

years of publication

  • Jin X. et al., 2016

    A

    Cochrane systematic review with meta-analysis

    5 RCTs, total number of people not reported

    The review collected randomised studies on the use of Ganoderma lucidum in the context of oncological treatment. The authors noted unsatisfactory methodological quality of the primary studies, incomplete outcome reporting, no long-term survival data, and adverse events reported in only one study.

    PMID 27045603
  • Klupp N.L. et al., 2015

    A

    Cochrane systematic review with meta-analysis

    5 studies, 398 people

    The review collected randomised studies on the effect of Ganoderma lucidum on cardiovascular risk factors in people with type 2 diabetes. The authors noted that only 3 of 5 studies provided data suitable for statistical analysis.

    PMID 25686270
  • Jafari A. et al., 2025

    B

    systematic review with meta-analysis, GRADE assessment

    17 RCTs, 971 people

    The review collected clinical trials on Ganoderma lucidum supplementation regarding anthropometric, metabolic, inflammatory and liver markers. GRADE-assessed evidence quality was very low for all analysed outcomes.

    PMID 40510787
  • Zhong L. et al., 2019

    B

    systematic review with meta-analysis of RCTs

    23 studies, 4246 people

    The review collected randomised studies on Coriolus versicolor and Ganoderma lucidum preparations used as adjunct therapy in oncology patients. Studies were conducted almost exclusively in Asia, with heterogeneous preparations and doses.

    PMID 31333449
  • Klupp N.L. et al., 2016

    C

    RCT, double-blind, placebo-controlled

    84 people

    The study examined the effect of Ganoderma lucidum, alone and combined with Cordyceps sinensis, on glycaemic parameters and other cardiovascular risk factors in 84 people with type 2 diabetes and metabolic syndrome. Observation period limited to 16 weeks.

    PMID 27511742
  • Noguchi M. et al., 2008

    C

    RCT

    88 men over 49 years old

    The study examined the effect of an ethanol extract of Ganoderma lucidum on lower urinary tract symptoms in 88 men over 49 years old. The authors recommended further evaluation on a larger sample and over a longer period.

    PMID 18097505
  • Aref M. et al., 2023

    E

    meta-analysis of animal studies · preclinical studies (in vitro and rodent)

    not applicable, 49 papers

    The review collected animal studies on the effect of Ganoderma lucidum on serum lipid profile. Dose variation between studies, scope limited to animal models.

    PMID 38116485
  • Tang W. et al., 2005

    C

    RCT, double-blind, placebo-controlled

    132 people (China)

    The study examined the effect of 8 weeks of taking a Ganoderma lucidum polysaccharide extract on a neurasthenia symptom severity scale score in 132 Chinese patients. Limitations were not stated explicitly in the abstract.

    PMID 15857210
  • Cui X.Y. et al., 2012

    E

    animal study (rats) · preclinical studies (in vitro and rodent)

    not applicable

    The rat study examined the effect of a 3-day Ganoderma lucidum extract administration (80 mg/kg) on total sleep time and NREM sleep, and on TNF-α levels in blood and brain, using TNF-α blocking antibodies to test the mechanism.

    PMID 22207209
  • Chu Q.P. et al., 2007

    E

    animal study (rats) · preclinical studies (in vitro and rodent)

    not applicable

    The rat study examined the effect of an aqueous extract (80 and 120 mg/kg) on sleep architecture in healthy animals and on pentobarbital-induced sleep, using flumazenil to test the GABAergic mechanism.

    PMID 17383716
  • Wang X. et al., 2025

    C

    RCT, double-blind, placebo-controlled

    110 randomised (55/group in final analysis), 12 weeks

    The study examined the effect of 12 weeks of Ganoderma lucidum spore oil supplementation (3 g daily, approx. 1 g triterpenes) on lipid profile and kidney/liver safety in people with borderline elevated triglycerides. Limited to a population with borderline hypertriglyceridemia and a short 12-week observation period.

    PMID 40077714

Evidence levels: A · Cochrane review · B · systematic review · C · placebo RCT · D · pilot RCT · E · preclinical studies

What these studies don't say

  • Samples are usually small, most from a single population.
  • Results describe research interventions, not a dietary supplement.
  • The presence of a study is not a health claim.

Source: Aloha Fungi literature review, 1 September 2026; entries verified via PubMed or by DOI (Crossref). See the research

Discover functional mushrooms

© 2026 Aloha Fungi™